Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Unitaid and Uganda Country Background Key Indicators Country Region4 Total Population, in ‘000 (2015)1 39 032 989 173 GDP per capita, PPP in $ (2015)2 1 851.0 3 714.1 Healthy life expectancy at birth, in years (2015) 54.0 52.3 Under 5 mortality rate, per 1,000 live births (2015)1 54.6 81.3 HIV prevalence (2015) 1 7.1 [6.6 - 7.7] 7.1 [6.6 - 7.6] New HIV infections among adults 15-49 years old, per 1000 uninfected population (2014)1 6.0 2.6 TB incidence, per 100 000 population (2014)1 161 281 Malaria incidence, per 1000 population at risk (2013)1 231.8 268.6 3 Unitaid investments in Uganda (2006-2015) Malaria 24% Total amount of investments: $154.3 Million Unitaid investments, % TB 1% HIV 75% HIV Malaria TB Active Grants5 Core Investment Area Project Lead Grantee Project Duration HIV Demonstrate feasibility of treating HCV (co-infection) Improving access to diagnosis and treatment for hepatitis C in low- and middle-income countries Medicines sans frontiers 2015 - 2017 HIV diagnostic and monitoring tools Accelerating access to innovative point of care (POC) HIV diagnostics Phase 2a Clinton Health Access Initiative 2014 - 2016 Providing access to viral-load monitoring and early-infant diagnosis by SAMBA Diagnostics for the Real World 2014 - 2016 Accelerating access to innovative point-of-care (POC) diagnostics for HIV Clinton Health Access Initiative 2016 - 2020 HIV diagnostics Implementation of CD4 and viral load testing in decentralized, remote and resource-limited settings Medicines sans frontiers 2012 - 2016 Optimal antiretrovirals for HIV Treatment Dolutegravir in pregnant mothers and neonates (DolPHIN2 trial) University of Liverpool 2016 - 2021 Optimal antiretrovirals for HIV Treatment Accelerating patient access to optimal antiretrovirals Clinton Health Access Initiative 2016 – 2019 Paediatric HIV Innovation in antiretroviral paediatric market access (IPMA) Clinton Health Access Initiative 2014 - 2016 MALARIA Malaria diagnostics Sustainable quality control of rapid diagnostics tests for malaria Foundation for Innovative New Diagnostics 2013 - 2017 Treating Severe Malaria Better treatment for severe malaria (injectable artestunate) Medicines for Malaria Venture 2013 - 2016 Better treatment for severe malaria (inter-rectal artesunate) Medicines for Malaria Venture 2013 - 2016 Addressing neglected childhood tuberculosis (STEP-TB) TB Alliance 2013 - 2016 EXPAND-TB project WHO-Global TB Programme 2013 - 2016 Paediatric TB TB diagnostics 1. 2. 3. 4. 5. World Health Statistics, 2016, available at http://www.who.int/gho/publications/world_health_statistics/2016/Annex_B/en/ The World Bank, 2015, Uganda and and Sub-Saharan Africa region, available at http://data.worldbank.org/indicator/NY.GDP.PCAP.PP.CD UNAIDS, AIDSinfo, 2015, available at http://aidsinfo.unaids.org/ For all WHO indicators Region refers to th WHO Region-Africa (AFRO), for indicator on GDP per capita Region refers to the World Bank Sub-Saharan Africa, for indicator on HIV prevalence - Region refers to UNAIDS East and Southern Africa Including grants that closed 6 months before the date of update. Last Update January 2017 TB